What’s New

Article

Mar 19, 2024

Countdown to Discovery: Previewing the Upcoming GI Clinical Trial Conferences In 2024

Explore GI clinical trial conferences in 2024 with our curated roster of events. This chronological listing offers an overview of the most influential gatherings worldwide, providing unparalleled oppo…

Read Now

News

Jan 8, 2024

Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer

London, Ontario, Canada, January 8, 2024 – Alimentiv Inc. (“Alimentiv”) is pleased to announce the appointment of Pierre Gaudreault as its Chief Executive Officer, effective January 2024. Th…

Read Now
View All News Videos Articles Publications Life At Alimentiv

Publication

May 29, 2023

Standardizing Scoring Conventions for Crohn’s Disease Endoscopy: An International RAND/UCLA Appropriateness Study

Brian G Feagan, Christopher Ma, Geert D’Haens, Guangyong Zou, Vipul Jairath.

Read Now

Publication

May 29, 2023

Systematic review and meta-analysis of randomised controlled trials: Medical therapies for the treatment and prevention of pouchitis

Christopher Ma, Rocio Sedano, Vipul Jairath.

Read Now

Publication

May 1, 2023

Advanced Combination Treatment With Biologic Agents and Novel Small Molecule Drugs for Inflammatory Bowel Disease

Brian G Feagan, Christopher Ma, Vipul Jairath.

Read Now

Publication

Apr 24, 2023

Real-World multicentre observational study with Pop-PK modelling to evaluate the exposure-response relationship of vedolizumab in IBD

Brian Feagan, Niels Vande Casteele.

Read Now

Publication

Apr 17, 2023

ATRC Review: IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Alimentiv Translational Research Consortium (ATRC), Niels Vande Casteele.

Read Now

Publication

Apr 1, 2023

Endoscopic and Histological Placebo Rates in Crohn’s Disease Clinical Trials: A Systematic Review and Meta-analysis

Brian G Feagan, Christopher Ma, Vipul Jairath.

Read Now